Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

MGNX

MacroGenics (MGNX)

MacroGenics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:MGNX
DataHoraFonteTítuloCódigoCompanhia
25/09/202417:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MGNXMacroGenics Inc
23/09/202406:45PR Newswire (US)Shareholders that lost money on MacroGenics, Inc.(MGNX) Urged to Join Class Action - Contact The Gross Law Firm to Learn MoreNASDAQ:MGNXMacroGenics Inc
19/09/202406:45PR Newswire (US)The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 24, 2024 in MacroGenics Lawsuit - MGNXNASDAQ:MGNXMacroGenics Inc
17/09/202409:30PR Newswire (US)MacroGenics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MGNXNASDAQ:MGNXMacroGenics Inc
16/09/202417:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MGNXMacroGenics Inc
16/09/202406:45PR Newswire (US)The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of MacroGenics, Inc.(MGNX) ShareholdersNASDAQ:MGNXMacroGenics Inc
15/09/202404:00GlobeNewswire Inc.MacroGenics Announces Updated Efficacy & Safety Data from TAMARACK Phase 2 Study of Vobra Duo in mCRPC Patients at ESMO Congress 2024NASDAQ:MGNXMacroGenics Inc
12/09/202406:45PR Newswire (US)Class Action Filed Against MacroGenics, Inc. (MGNX) - September 24, 2024 Deadline to Join - Contact The Gross Law FirmNASDAQ:MGNXMacroGenics Inc
09/09/202411:24PR Newswire (US)The Gross Law Firm Reminds MacroGenics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 24, 2024 - MGNXNASDAQ:MGNXMacroGenics Inc
08/09/202420:10GlobeNewswire Inc.MacroGenics Announces TAMARACK Phase 2 Data Presentation at ESMO Congress 2024NASDAQ:MGNXMacroGenics Inc
05/09/202406:45PR Newswire (US)Investors who lost money on MacroGenics, Inc.(MGNX) should contact The Gross Law Firm about pending Class Action - MGNXNASDAQ:MGNXMacroGenics Inc
29/08/202406:45PR Newswire (US)MacroGenics, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before September 24, 2024 to Discuss Your Rights - MGNXNASDAQ:MGNXMacroGenics Inc
22/08/202406:45PR Newswire (US)September 24, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against MGNXNASDAQ:MGNXMacroGenics Inc
15/08/202406:45PR Newswire (US)MacroGenics, Inc. Class Action: The Gross Law Firm Reminds MacroGenics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 24, 2024 - MGNXNASDAQ:MGNXMacroGenics Inc
12/08/202406:30PR Newswire (US)The Gross Law Firm Notifies Shareholders of MacroGenics, Inc.(MGNX) of a Class Action Lawsuit and an Upcoming DeadlineNASDAQ:MGNXMacroGenics Inc
08/08/202406:45PR Newswire (US)MacroGenics, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before September 24, 2024 to Discuss Your Rights - MGNXNASDAQ:MGNXMacroGenics Inc
06/08/202417:01GlobeNewswire Inc.MacroGenics Provides Update on Corporate Progress, Second Quarter 2024 Financial ResultsNASDAQ:MGNXMacroGenics Inc
30/07/202417:10GlobeNewswire Inc.MacroGenics Provides Vobramitamab Duocarmazine UpdateNASDAQ:MGNXMacroGenics Inc
30/07/202417:01GlobeNewswire Inc.MacroGenics Announces Achievement of $100 Million in Milestones Related to Retifanlimab Collaboration with IncyteNASDAQ:MGNXMacroGenics Inc
11/06/202408:45GlobeNewswire Inc.MacroGenics to Participate in Upcoming Investor ConferenceNASDAQ:MGNXMacroGenics Inc
04/06/202417:53Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:MGNXMacroGenics Inc
24/05/202418:08Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:MGNXMacroGenics Inc
23/05/202417:22Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:MGNXMacroGenics Inc
13/05/202408:30GlobeNewswire Inc.MacroGenics to Participate in Upcoming Investor ConferencesNASDAQ:MGNXMacroGenics Inc
09/05/202417:02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MGNXMacroGenics Inc
09/05/202417:01GlobeNewswire Inc.MacroGenics Provides Update on Corporate Progress, First Quarter 2024 Financial Results and Interim TAMARACK Phase 2 Study DataNASDAQ:MGNXMacroGenics Inc
03/05/202408:30GlobeNewswire Inc.MacroGenics Announces Date of First Quarter 2024 Financial Results Conference CallNASDAQ:MGNXMacroGenics Inc
03/04/202417:30GlobeNewswire Inc.MacroGenics Provides Phase 2 TAMARACK Study Early Interim Safety Data and Plans for Future DisclosuresNASDAQ:MGNXMacroGenics Inc
07/03/202418:01GlobeNewswire Inc.MacroGenics Provides Update on Corporate Progress and 2023 Financial ResultsNASDAQ:MGNXMacroGenics Inc
06/03/202418:16Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MGNXMacroGenics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:MGNX